Acadia Pharmaceuticals (ACAD) PT Raised to $23 at Oppenheimer

July 14, 2023 7:30 AM EDT Send to a Friend

Oppenheimer analyst Jay Olson raised ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Acadia Pharmaceuticals (ACAD) PT Raised to $23 at Oppenheimer

Member Login

Free News Feed